Discontinuation report ORCIPRENALINE
Report ID | 108373 |
Drug Identification Number | 02236783 |
Brand name | ORCIPRENALINE |
Common or Proper name | ORCIPRENALINE |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | ORCIPRENALINE SULFATE |
Strength(s) | 2MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL |
Packaging size | 250ML |
ATC code | R03CB |
ATC description | ADRENERGICS FOR SYSTEMIC USE |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-03-10 |
Remaining supply date | 2020-03-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2020-03-11 | English | Compare |
v2 | 2020-03-10 | French | Compare |
v1 | 2020-03-10 | English | Compare |
Showing 1 to 3 of 3